These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Evaluation of the functional status of hepatic microsomal enzymes in workers exposed to carbon dioxide and vinyl chloride by using the antipyrine test]. Lutz W; Stankiewicz A; Krajewska B Med Pr; 1987; 38(3):157-66. PubMed ID: 3118136 [TBL] [Abstract][Full Text] [Related]
27. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species. McManus ME; Ilett KF Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309 [TBL] [Abstract][Full Text] [Related]
28. Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers. Nakazawa Y; Chiba K; Imatoh N; Kotorii T; Sakamoto T; Ishizaki T Drug Alcohol Depend; 1983 Apr; 11(2):201-7. PubMed ID: 6861617 [TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. Rivière JH; Back DJ; Breckenridge AM; Howells RE Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153 [TBL] [Abstract][Full Text] [Related]
30. Short term anti-tubercular drug therapy and hepatic microsomal enzyme activity. Antipyrine metabolism as an index. Hamide A; Sivagnanam G; Raveendran R; Adithan C; Sivaraman V; Chandrasekar S J Assoc Physicians India; 1990 Sep; 38(9):631-2. PubMed ID: 2266077 [TBL] [Abstract][Full Text] [Related]
31. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine. Higuchi T; Nakamura T; Uchino H Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270 [TBL] [Abstract][Full Text] [Related]
32. Increased values of antipyrine clearance in type IV hyperlipoproteinemia. Bedeleanu D; Trif I; Lötsch JC; Cucuianu MP Med Interne; 1986; 24(3):183-90. PubMed ID: 3775212 [TBL] [Abstract][Full Text] [Related]
33. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980 [TBL] [Abstract][Full Text] [Related]
34. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample. Loft S; Nielsen AJ; Borg BE; Poulsen HE Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365 [TBL] [Abstract][Full Text] [Related]
35. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers. Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285 [TBL] [Abstract][Full Text] [Related]
36. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man. Gram LF; Andreasen PB; Overo KF; Christiansen J Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758 [TBL] [Abstract][Full Text] [Related]
37. Accuracy and clinical utility of simplified tests of antipyrine metabolism. Farrell GC; Zaluzny L Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495 [TBL] [Abstract][Full Text] [Related]
38. Elimination of antipyrine from saliva as a measure of metabolism in man. Welch RM; DeAngelis RL; Wingfield M; Farmer TW Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815 [TBL] [Abstract][Full Text] [Related]